Clinical Trials Logo

Clinical Trial Summary

Human immune function and intestinal microbiota are suggested to be altered within long-duration stay in space. Accumulated evidences on earth support that Lactobacillus casei strain Shirota (LcS) is a promising probiotic strain on improvement of immune function and intestinal microbiota. This study aims to investigate the impact of long-duration spaceflight as well as intake of LcS on the international space station (ISS), on immune system and intestinal microbiota in astronauts.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms

  • Immune Function and Intestinal Microbiota

NCT number NCT02618005
Study type Interventional
Source Yakult Honsha Co., LTD
Contact
Status Active, not recruiting
Phase N/A
Start date October 2015
Completion date March 2023